Compared with other glucose-lowering drugs, semaglutide is not associated with the risk for neovascular age-related macular degeneration in adults with type 2 diabetes.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/study-finds-no-link-between-semaglutide-and-amd-risk-2026a1000j7y?src=rss
Author :
Publish date : 2026-06-09 10:16:00
Copyright for syndicated content belongs to the linked Source.
